Pathogens (Oct 2022)

Serological Screening for Middle East Respiratory Syndrome Coronavirus and Hepatitis E Virus in Camels in Kazakhstan

  • Kobey Karamendin,
  • Aigerim Seidalina,
  • Temirlan Sabyrzhan,
  • Sardor Nuralibekov,
  • Yermukhammet Kasymbekov,
  • Symbat Suleimenova,
  • Elizaveta Khan,
  • Oralbek Alikhanov,
  • Uldana Narsha,
  • Kalya Erkekulova,
  • Aidyn Kydyrmanov

DOI
https://doi.org/10.3390/pathogens11111224
Journal volume & issue
Vol. 11, no. 11
p. 1224

Abstract

Read online

After the recent Middle East Respiratory Syndrome coronavirus (MERS–CoV) pandemic in 2013, more attention has been paid to the camel as an important source of zoonotic viral infections. Almost simultaneously, in 2013, new genotypes 7 and 8 of the hepatitis E virus (HEV) were discovered in dromedary and Bactrian camels, respectively. HEV 7 was further shown to be associated with chronic viral hepatitis in a transplant recipient. In this study, serological screening for antibodies to MERS-CoV and hepatitis E virus was carried out on large camel farms in the south and west of Kazakhstan. 6.42% of the tested camels were found to be positive for antibodies to the hepatitis E virus, which indicates its circulation in local camel population. For the first time, antibodies to the hepatitis E virus were found in Bactrians, which have been little studied to date. Antibodies to MERS-CoV were not found in the camel sera.

Keywords